G Villacampa,N M Tung,S Pernas,L Paré,C Bueno-Muiño,I Echavarría,S López-Tarruella,M Roche-Molina,M Del Monte-Millán,M Marín-Aguilera,F Brasó-Maristany,A G Waks,T Pascual,O Martínez-Sáez,A Vivancos,P F Conte,V Guarneri,M Vittoria Dieci,G Griguolo,J Cortés,A Llombart-Cussac,M Muñoz,M Vidal,B Adamo,A C Wolff,A DeMichele,P Villagrasa,J S Parker,C M Perou,A Fernandez-Martinez,L A Carey,E A Mittendorf,M Martín,A Prat,S M Tolaney
G Villacampa
SOLTI Breast Cancer Research Group, Barcelona, Spain; Oncology Data Science, Vall d’Hebron Institute of Oncology, Barcelona, Spain.
N M Tung
Beth Israel, Boston, USA.
S Pernas
Medical Oncology Department, Catalan Institute of Oncology, 08908, L’Hospitalet de Llobregat, Barcelona, Spain.
L Paré
Reveal Genomics, Barcelona, Spain.
C Bueno-Muiño
Medical Oncology Department, Hospital Infanta Cristina (Parla), Fundación de Investigación Biomédica del H.U. Puerta de Hierro, Majadahonda, 28009 Madrid, Spain.
I Echavarría
Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CiberOnc, Madrid, Spain.
S López-Tarruella
Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañon (IiSGM), CIBERONC, Geicam, Universidad Complutense, 28007 Madrid, Spain.
M Roche-Molina
Department of Medical Oncology, Hospital General Universitario Gregorio Marañón Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
M Del Monte-Millán
Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CiberOnc, Madrid, Spain.
M Marín-Aguilera
Reveal Genomics, Barcelona, Spain.
F Brasó-Maristany
Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Department of Medical Oncology, Hospital Clinic of Barcelona, Spain.
A G Waks
Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
T Pascual
SOLTI Breast Cancer Research Group, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Department of Medical Oncology, Hospital Clinic of Barcelona, Spain.
O Martínez-Sáez
Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Department of Medical Oncology, Hospital Clinic of Barcelona, Spain.
A Vivancos
Cancer Genomics Group, VHIO, Barcelona, Spain.
P F Conte
Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Istituto Oncologico Veneto, IRCCS, Padova, Italy.
V Guarneri
Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Istituto Oncologico Veneto, IRCCS, Padova, Italy.
M Vittoria Dieci
Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Istituto Oncologico Veneto, IRCCS, Padova, Italy.
G Griguolo
Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Istituto Oncologico Veneto, IRCCS, Padova, Italy.
J Cortés
International Breast Cancer Center, Pangaea Oncology, Quirónsalud Group, Barcelona, Spain.
A Llombart-Cussac
Arnau de Vilanova Hospital, Universidad Católica de Valencia, Valencia, Spain.
M Muñoz
Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Department of Medical Oncology, Hospital Clinic of Barcelona, Spain.
M Vidal
Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Department of Medical Oncology, Hospital Clinic of Barcelona, Spain.
B Adamo
Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Department of Medical Oncology, Hospital Clinic of Barcelona, Spain.
A C Wolff
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, USA.
A DeMichele
Department of Oncology, University of Pennsylvania, Philadelphia, USA.
P Villagrasa
Reveal Genomics, Barcelona, Spain.
J S Parker
Lineberger Comprehensive Cancer Center; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, USA.
C M Perou
Lineberger Comprehensive Cancer Center; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, USA.
A Fernandez-Martinez
Lineberger Comprehensive Cancer Center; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, USA.
L A Carey
Lineberger Comprehensive Cancer Center; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, USA.
E A Mittendorf
Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Division of Breast Surgery, Department of Surgery, Brigham and Women’s Hospital, Boston, MA, USA.
M Martín
Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañon (IiSGM), CIBERONC, Geicam, Universidad Complutense, 28007 Madrid, Spain.
A Prat
Reveal Genomics, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Department of Medical Oncology, Hospital Clinic of Barcelona, Spain; Institute of Oncology (IOB)-Quirón, Barcelona, Spain. Electronic address: alprat@clinic.cat.
S M Tolaney
Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: sara_tolaney@dfci.harvard.edu.
